Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Workup of the abnormal Pap test.

R E Bristow1, F J Montz

  • 1Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Clinical Cornerstone
|November 4, 2000
PubMed
Summary

The Papanicolaou (Pap) test is a highly effective and cost-efficient method for cervical cancer screening. It significantly reduces cervical cancer incidence and mortality by detecting preinvasive and early invasive disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Perioperative fluid status and surgical outcomes in patients undergoing cytoreductive surgery for advanced epithelial ovarian cancer.

Gynecologic oncology·2016
Same author

Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.

Gynecologic oncology reports·2016
Same author

Cost-effectiveness analysis of a multivariate index assay compared to modified American College of Obstetricians and Gynecologists criteria and CA-125 in the triage of women with adnexal masses.

Current medical research and opinion·2015
Same author

Management of the abnormal papanicolaou smear during pregnancy: lessons for quality improvement.

Journal of lower genital tract disease·2015
Same author

Training cytotechnologists to perform papanicolaou smear screening: development and testing of a third world program.

Journal of lower genital tract disease·2015

Area of Science:

  • Gynecologic Oncology
  • Cytopathology
  • Preventive Medicine

Background:

  • Cervical cancer screening has historically relied on cytologic evaluation.
  • The Papanicolaou (Pap) test, developed in the 1940s, is a cornerstone of cervical cancer detection.
  • Despite advances, cervical cancer remains a significant health concern, necessitating effective screening.

Purpose of the Study:

  • To review the clinical significance and natural history of abnormal cervical cytologic diagnoses.
  • To outline practical management protocols for cervical dysplasia.
  • To emphasize the importance of physician familiarity with Pap test results and treatment options.

Main Methods:

  • Review of established cytologic evaluation techniques for cervical and vaginal cells.
  • Analysis of data on the efficacy of the Papanicolaou (Pap) test in cancer screening.
  • Delineation of management protocols for various grades of cervical dysplasia.

Main Results:

  • The Papanicolaou (Pap) test is the most effective and cost-efficient method for cervical cancer screening.
  • Established screening programs utilizing the Pap test have demonstrably decreased cervical cancer incidence and mortality.
  • Approximately 5% of the over 50 million annual Pap tests in the US yield abnormal results, requiring further management.

Conclusions:

  • The Papanicolaou (Pap) test remains a vital tool in reducing cervical cancer burden.
  • Primary care physicians must be knowledgeable in managing abnormal cervical cytology findings.
  • Standardized management protocols are essential for addressing the spectrum of cervical dysplasia.

Related Experiment Videos